PlainRecalls
FDA Drug Moderate Class II Terminated

Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reported: April 12, 2023 Initiated: March 20, 2023 #D-0492-2023

Product Description

Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.

Reason for Recall

cGMP Deviations

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
a) 58 bottles, b) 6 bottles
Distribution
RemedyRepack distributed product to consignees nationwide within the United States
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.. Recalled by RemedyRepack Inc.. Units affected: a) 58 bottles, b) 6 bottles.
Why was this product recalled?
cGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on April 12, 2023. Severity: Moderate. Recall number: D-0492-2023.